Bottom is behind us Moderna has gone through panic selling which tells me a generational bottom has probably formed.
MRNA - short term profit targets $46 - $49MRNA - short term profit targets $46 - $49
17K call options at strike $41.5 expiring 31 Jan
17K PuT options at strike $40 expiring 21 Mar
12R Moderna LongExpecting a move up to the red supply zone.
Approx target 100, but being conservative by going shy of that.
There is strong confluence with other biotech companies here with many others also looking bullish for the following weeks.
Will MRNA rotate? CVS, UNH, JNJ all rotating in q1 of 2025. Will MRNA start to roll over and complete the weekly harmonic pattern and go for the TYPE 1 cycle? Long hold but seems like a no brainer. 🥂
Bird Flu - Short Squeeze incoming?Strong downtrend, ABC correction with the final C wave possibly in. Potential for a short squeeze as Moderna receives funding to develop a Bird Flu vaccine for the ongoing outbreak.
The financials don’t look great, this would be a short term trade with a tight stop loss.
Not financial advice, ju
$MRNA to $90-115 | 100-150% upside in FY 2025- NASDAQ:MRNA most of the people are familiar with the vaccine stocks from pandemic fiasco.
- This company is beaten down to the ground and has low market cap as compared to other biopharma stocks.
- 2025 would be easier for merger and acquisition which will be good for moderna as it might get a
$MRNA has 50-100% upside from $43 in FY 2025- NASDAQ:MRNA had one of the worst year in 2024. However, cash position is underestimated and the market cap has gotten very low for a company which has proven it's excellence in manufacturing drug and research.
- NASDAQ:MRNA is working on cancer prevention vaccines which might get approvals
Moderna Bullish Outlook With a broken Resistance , an oversold RSI and a beautiful oversold MFI , we anticipate MRNA to rise to the top of the descending and potential top of bull flag formation at $125.00 in the near term
- 160% ROI from $48.00 to $125.00
Moderna (MRNA) Down 92% from All-Time High – What's Next?Overview:
Moderna (MRNA) has fallen sharply, trading 92% below its all-time high of $497.49 (reached in 2021). With this massive decline, investors might wonder: Is the stock poised for a recovery or headed lower?
Key Insights:
Support Levels:
Current price hovers near the 2020 pre-pandemic breako
The Share Price of Moderna (MRNA) Surged Over 10% in a DayThe Share Price of Moderna (MRNA) Surged Over 10% in a Day
As shown by the chart of pharmaceutical company Moderna (MRNA):
→ 2024 was an extremely difficult year, with the price falling by approximately 60%;
→ however, in early 2025, we can see signs of renewed strength.
During yesterday’s sessio
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where MRNA is featured.
